UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Hilltop Holdings Inc.

Hilltop Holdings Inc. increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 205.1% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 21,069 shares of the healthcare conglomerate’s stock after acquiring an additional 14,163 shares during the quarter. UnitedHealth Group makes up 0.8% of Hilltop Holdings Inc.’s portfolio, making the stock its 16th biggest position. Hilltop Holdings Inc.’s holdings in UnitedHealth Group were worth $12,318,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of UNH. Garden State Investment Advisory Services LLC increased its holdings in shares of UnitedHealth Group by 9.7% in the 3rd quarter. Garden State Investment Advisory Services LLC now owns 1,151 shares of the healthcare conglomerate’s stock valued at $676,000 after acquiring an additional 102 shares during the last quarter. Cinctive Capital Management LP bought a new position in shares of UnitedHealth Group in the 3rd quarter worth about $3,619,000. Concentric Capital Strategies LP grew its position in shares of UnitedHealth Group by 40.2% during the 3rd quarter. Concentric Capital Strategies LP now owns 3,843 shares of the healthcare conglomerate’s stock valued at $2,247,000 after buying an additional 1,101 shares during the last quarter. Benjamin Edwards Inc. boosted its stake in UnitedHealth Group by 1,275.3% in the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock valued at $26,060,000 after acquiring an additional 41,308 shares during the period. Finally, Atom Investors LP raised its position in shares of UnitedHealth Group by 5,098.1% during the 3rd quarter. Atom Investors LP now owns 21,676 shares of the healthcare conglomerate’s stock worth $12,674,000 after purchasing an additional 21,259 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.2 %

UNH stock opened at $611.50 on Monday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The firm has a market capitalization of $562.75 billion, a P/E ratio of 39.75, a P/E/G ratio of 1.79 and a beta of 0.58. The company’s 50 day simple moving average is $585.43 and its 200-day simple moving average is $556.65.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the firm earned $6.56 earnings per share. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.37%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

Analysts Set New Price Targets

UNH has been the topic of several analyst reports. Royal Bank of Canada dropped their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. KeyCorp began coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective on the stock. Truist Financial restated a “buy” rating and issued a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Stephens decreased their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Finally, TD Cowen boosted their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $618.26.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.